Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Influenza

  Free Subscription


18.07.2022

8 Antiviral Res
1 BMC Pediatr
8 BMJ
4 Cell
1 J Exp Med
1 J Gen Virol
2 Lancet
1 MMWR Morb Mortal Wkly Rep
3 PLoS Comput Biol
24 PLoS One
4 Vaccine


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Antiviral Res

  1. KIM EH, Lee BW, Ryu B, Cho HM, et al
    Inhibition of a broad range of SARS-CoV-2 variants by antiviral phytochemicals in hACE2 mice.
    Antiviral Res. 2022;204:105371.
    PubMed         Abstract available

  2. SEEPHETDEE C, Bhukhai K, Buasri N, Leelukkanaveera P, et al
    A circular mRNA vaccine prototype producing VFLIP-X spike confers a broad neutralization of SARS-CoV-2 variants by mouse sera.
    Antiviral Res. 2022 Jun 27:105370. doi: 10.1016/j.antiviral.2022.105370.
    PubMed         Abstract available

  3. KARIM M, Saul S, Ghita L, Sahoo MK, et al
    Numb-associated kinases are required for SARS-CoV-2 infection and are cellular targets for antiviral strategies.
    Antiviral Res. 2022 Jun 20:105367. doi: 10.1016/j.antiviral.2022.105367.
    PubMed         Abstract available

  4. ZHOU M, Liu Y, Cao J, Dong S, et al
    Bergamottin, a bioactive component of bergamot, inhibits SARS-CoV-2 infection in golden Syrian hamsters.
    Antiviral Res. 2022 Jun 19:105365. doi: 10.1016/j.antiviral.2022.105365.
    PubMed         Abstract available

  5. CIVRA A, Costantino M, Cavalli R, Adami M, et al
    27-Hydroxycholesterol inhibits rhinovirus replication in vitro and on human nasal and bronchial histocultures without selecting viral resistant variants.
    Antiviral Res. 2022;204:105368.
    PubMed         Abstract available

  6. HERNANDEZ S, Feracci M, De Jesus CT, El Kazzi P, et al
    Identification of potent inhibitors of arenavirus and SARS-CoV-2 exoribonucleases by fluorescence polarization assay.
    Antiviral Res. 2022 Jun 15:105364. doi: 10.1016/j.antiviral.2022.105364.
    PubMed         Abstract available

  7. MELO-FILHO CC, Bobrowski T, Martin HJ, Sessions Z, et al
    Conserved coronavirus proteins as targets of broad-spectrum antivirals.
    Antiviral Res. 2022 Jun 9:105360. doi: 10.1016/j.antiviral.2022.105360.
    PubMed         Abstract available

  8. MERCORELLI B, Desantis J, Celegato M, Bazzacco A, et al
    Discovery of novel SARS-CoV-2 inhibitors targeting the main protease M(pro) by virtual screenings and hit optimization.
    Antiviral Res. 2022;204:105350.
    PubMed         Abstract available


    BMC Pediatr

  9. ARUN S, Cherian TG, Philip C
    Multisystem inflammatory syndrome in a neonate with severe hemophilia - a diagnostic challenge in COVID times: a case report.
    BMC Pediatr. 2022;22:397.
    PubMed         Abstract available


    BMJ

  10. STRAIN D
    Removing special covid leave will only undervalue staff and threaten patient safety.
    BMJ. 2022;378:o1684.
    PubMed        

  11. TAYLOR L
    Covid-19: WHO urges countries to plug immunity gaps as global infections rise.
    BMJ. 2022;378:o1685.
    PubMed        

  12. DYER O
    Covid vaccines: Canada to dispose of 13.6 million AstraZeneca doses owing to lack of demand.
    BMJ. 2022;378:o1700.
    PubMed        

  13. KAMINSKAITE V, Bluemel AH
    Impact of the covid-19 pandemic on medical school applicants.
    BMJ. 2022;378:o1398.
    PubMed        

  14. TANNE JH
    Covid-19: FDA authorises pharmacists to prescribe Paxlovid.
    BMJ. 2022;378:o1695.
    PubMed        

  15. BOYLE A
    Workforce: the persistent victim of the covid-19 pandemic.
    BMJ. 2022;378:o1702.
    PubMed        

  16. WILKINSON E
    Covid-19: Hospitals and GP clinics return to universal mask wearing as rates rise.
    BMJ. 2022;378:o1712.
    PubMed        

  17. MAHASE E
    Covid-19: Ethnic minority staff felt "vulnerable" during pandemic, says senior leader.
    BMJ. 2022;378:o1715.
    PubMed        


    Cell

  18. TUEKPRAKHON A, Nutalai R, Dijokaite-Guraliuc A, Zhou D, et al
    Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum.
    Cell. 2022;185:2422-2433.
    PubMed         Abstract available

  19. KAO J, Frankland PW
    COVID fog demystified.
    Cell. 2022;185:2391-2393.
    PubMed         Abstract available

  20. FERNANDEZ-CASTANEDA A, Lu P, Geraghty AC, Song E, et al
    Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation.
    Cell. 2022;185:2452-2468.
    PubMed         Abstract available

  21. ZHANG Z, Mateus J, Coelho CH, Dan JM, et al
    Humoral and cellular immune memory to four COVID-19 vaccines.
    Cell. 2022;185:2434-2451.
    PubMed         Abstract available


    J Exp Med

  22. AGUDELO M, Muecksch F, Schaefer-Babajew D, Cho A, et al
    Plasma and memory antibody responses to Gamma SARS-CoV-2 provide limited cross-protection to other variants.
    J Exp Med. 2022;219.
    PubMed         Abstract available


    J Gen Virol

  23. SHARTOUNY JR, Lowen AC
    Message in a bottle: mRNA vaccination for influenza.
    J Gen Virol. 2022;103.
    PubMed         Abstract available


    Lancet

  24. SACCO C, Del Manso M, Mateo-Urdiales A, Rota MC, et al
    Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.
    Lancet. 2022 Jun 30. pii: S0140-6736(22)01185.
    PubMed         Abstract available

  25. LADHANI SN
    COVID-19 vaccination for children aged 5-11 years.
    Lancet. 2022 Jun 30. pii: S0140-6736(22)01245.
    PubMed        


    MMWR Morb Mortal Wkly Rep

  26. SINGSON JRC, Kirley PD, Pham H, Rothrock G, et al
    Factors Associated with Severe Outcomes Among Immunocompromised Adults Hospitalized for COVID-19 - COVID-NET, 10 States, March 2020-February 2022.
    MMWR Morb Mortal Wkly Rep. 2022;71:878-884.
    PubMed         Abstract available


    PLoS Comput Biol

  27. ANDRADE J, Duggan J
    Inferring the effective reproductive number from deterministic and semi-deterministic compartmental models using incidence and mobility data.
    PLoS Comput Biol. 2022;18:e1010206.
    PubMed         Abstract available

  28. ZHAO S, Chong MKC, Ryu S, Guo Z, et al
    Characterizing superspreading potential of infectious disease: Decomposition of individual transmissibility.
    PLoS Comput Biol. 2022;18:e1010281.
    PubMed         Abstract available

  29. EGUCHI RR, Choe CA, Huang PS
    Ig-VAE: Generative modeling of protein structure by direct 3D coordinate generation.
    PLoS Comput Biol. 2022;18:e1010271.
    PubMed         Abstract available


    PLoS One

  30. TARIF AB, Ramadan M, Yin M, Sharkas G, et al
    Infection prevention and control risk factors in health workers infected with SARS-CoV-2 in Jordan: A case control study.
    PLoS One. 2022;17:e0271133.
    PubMed         Abstract available

  31. LUSIDA MAP, Salamah S, Jonatan M, Wiyogo IO, et al
    Prevalence of and risk factors for depression, anxiety, and stress in non-hospitalized asymptomatic and mild COVID-19 patients in East Java province, Indonesia.
    PLoS One. 2022;17:e0270966.
    PubMed         Abstract available

  32. DAYEKH AY, Naseridine M, Dakroub F, Olleik A, et al
    Impact, obstacles and boundaries of patient partnership: A qualitative interventional study in Lebanon.
    PLoS One. 2022;17:e0270654.
    PubMed         Abstract available

  33. VAN GOOR HMR, van Loon K, Breteler MJM, Kalkman CJ, et al
    Circadian patterns of heart rate, respiratory rate and skin temperature in hospitalized COVID-19 patients.
    PLoS One. 2022;17:e0268065.
    PubMed         Abstract available

  34. BEREC L, Smid M, Pribylova L, Majek O, et al
    Protection provided by vaccination, booster doses and previous infection against covid-19 infection, hospitalisation or death over time in Czechia.
    PLoS One. 2022;17:e0270801.
    PubMed         Abstract available

  35. FIERRO A, Romano S, Liccardo A
    Vaccination and variants: Retrospective model for the evolution of Covid-19 in Italy.
    PLoS One. 2022;17:e0265159.
    PubMed         Abstract available

  36. JAFAR A, Dambul R, Dollah R, Sakke N, et al
    COVID-19 vaccine hesitancy in Malaysia: Exploring factors and identifying highly vulnerable groups.
    PLoS One. 2022;17:e0270868.
    PubMed         Abstract available

  37. YUBONPUNT P, Kunno J, Supawattanabodee B, Sumanasrethakul C, et al
    Prevalence of perceived stress and coping strategies among healthcare workers during the COVID-19 outbreak at Bangkok metropolitan, Thailand.
    PLoS One. 2022;17:e0270924.
    PubMed         Abstract available

  38. YIN J, Yuan N, Huang Z, Hu Z, et al
    Assessment of hypokalemia and clinical prognosis in Patients with COVID-19 in Yangzhou, China.
    PLoS One. 2022;17:e0271132.
    PubMed         Abstract available

  39. MOYER JD, Verhagen W, Mapes B, Bohl DK, et al
    How many people is the COVID-19 pandemic pushing into poverty? A long-term forecast to 2050 with alternative scenarios.
    PLoS One. 2022;17:e0270846.
    PubMed         Abstract available

  40. LI L, Xu B, Chen C, Cheng M, et al
    Do public employment services affect the self-rated health of migrant workers in China?
    PLoS One. 2022;17:e0270006.
    PubMed         Abstract available

  41. LEVANDOWSKI BA, Miller SB, Ran D, Pressman EA, et al
    Piling it on: Perceived stress and lack of access to resources among US-based LGBTQ+ community members during the COVID-19 pandemic.
    PLoS One. 2022;17:e0271162.
    PubMed         Abstract available

  42. GODOLPHIN PJ, Fisher DJ, Berry LR, Derde LPG, et al
    Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysis.
    PLoS One. 2022;17:e0270668.
    PubMed         Abstract available

  43. CALDARULO M, Olsen J, Frandell A, Islam S, et al
    COVID-19 and gender inequity in science: Consistent harm over time.
    PLoS One. 2022;17:e0271089.
    PubMed         Abstract available

  44. GAGNON F, Bhatt M, Zemek R, Webster RJ, et al
    Nasopharyngeal swabs vs. saliva sampling for SARS-CoV-2 detection: A cross-sectional survey of acceptability for caregivers and children after experiencing both methods.
    PLoS One. 2022;17:e0270929.
    PubMed         Abstract available

  45. ISMAIL A, Doghish AS, Elkhatib WF, Magdy AM, et al
    Clinical and chest computed tomography features of patients suffering from mild and severe COVID-19 at Fayoum University Hospital in Egypt.
    PLoS One. 2022;17:e0271271.
    PubMed         Abstract available

  46. MAGEE L, Knights F, Mckechnie DGJ, Al-Bedaery R, et al
    Facilitators and barriers to COVID-19 vaccination uptake among ethnic minorities: A qualitative study in primary care.
    PLoS One. 2022;17:e0270504.
    PubMed         Abstract available

  47. OKAI GA, Abekah-Nkrumah G
    The level and determinants of COVID-19 vaccine acceptance in Ghana.
    PLoS One. 2022;17:e0270768.
    PubMed         Abstract available

  48. DOU Y, Fan H, Yang X, Du Y, et al
    Impact of the COVID-19 pandemic on psychological distress and biological rhythm in China's general population: A path analysis model.
    PLoS One. 2022;17:e0271285.
    PubMed         Abstract available

  49. PRAKASH A, Jeyakumar Nathan R, Kini S, Victor V, et al
    Message framing and COVID-19 vaccine acceptance among millennials in South India.
    PLoS One. 2022;17:e0269487.
    PubMed         Abstract available

  50. SHOEMAKER RH, Panettieri RA Jr, Libutti SK, Hochster HS, et al
    Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer.
    PLoS One. 2022;17:e0271066.
    PubMed         Abstract available

  51. NAZARI T, Sadeghi F, Izadi A, Sameni S, et al
    COVID-19-associated fungal infections in Iran: A systematic review.
    PLoS One. 2022;17:e0271333.
    PubMed         Abstract available

  52. GUPTA M, Parameswaran GG, Sra MS, Mohanta R, et al
    Contact tracing of COVID-19 in Karnataka, India: Superspreading and determinants of infectiousness and symptomatic infection.
    PLoS One. 2022;17:e0270789.
    PubMed         Abstract available

  53. KONISHI T
    Mutations in SARS-CoV-2 are on the increase against the acquired immunity.
    PLoS One. 2022;17:e0271305.
    PubMed         Abstract available


    Vaccine

  54. WONG SC, Chan VW, Lam GKM, Yuen LL, et al
    The impact of personal coaching on influenza vaccination among healthcare workers before and during COVID-19 pandemic.
    Vaccine. 2022 Jun 27. pii: S0264-410X(22)00836.
    PubMed         Abstract available

  55. CHADWICK C, Friede M, Moen A, Nannei C, et al
    Technology transfer programme for influenza vaccines - Lessons from the past to inform the future.
    Vaccine. 2022 Jul 6. pii: S0264-410X(22)00826.
    PubMed        

  56. ZHANG Y, Wang Y, Jia C, Li G, et al
    Immunogenicity and safety of an egg culture-based quadrivalent inactivated non-adjuvanted subunit influenza vaccine in subjects >/=3 years: A randomized, multicenter, double-blind, active-controlled phase III, non-inferiority trial.
    Vaccine. 2022 Jul 7. pii: S0264-410X(22)00846.
    PubMed         Abstract available

  57. WYPLOSZ B, Fernandes J, Sultan A, Roche N, et al
    Pneumococcal and influenza vaccination coverage among at-risk adults: A 5-year French national observational study.
    Vaccine. 2022 Jul 7. pii: S0264-410X(22)00841.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: